U.S. approves HIV-prevention drug July 17, 2012 - 18:19 AMT PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said. The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners. Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure. A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling. Partner news  Top stories Serzh Sargsyan addressed a letter of condolence to Barack Obama on the destruction caused by Oklahoma City tornado. Hrach Berberyan: €2500 will be spent for the coverage of 1 hectare crop, whereas the price of one anti-hail station totals $30 000. The asteroid is said to measure in at about 1.7-miles long and will be about 3.6 million miles away from Earth as it passes. Artsrun Hovhannisyan: the helicopter wasn't damaged; there's no evidence as to the shooting except the accounts of the villagers.   Partner news |  Latest news Russian expert rules out Karabakh war renewal by Armenia  Alexander Krylov: the possibility of the renewal of Karabakh war should not be exaggerated in the face of the balance of power.German scientists ready to include Armenian petroglyphs in UNESCO list The scientists conducted a survey of ancient rock art, with a database of Armenian petroglyphs to be later developed.OSCE Minsk Group Co-Chairs won’t visit Artsakh French Co-Chair of the OSCE Minsk Group Jacques Faure said the co-chairs are not planning a visit to Nagorno Karabakh.Penguin reaches $75mln agreement in iBooks price fixing lawsuit In a press release, Penguin's parent company, Pearson, noted it had made a $40 million provision for settlement in its 2012 accounts. |
